Physician profile
Nahid Islam
NPI 1568662393
$1,055.13
in general payments reported to CMS, 2019-2025
19 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.89 · 2020: $236 · 2021: $362 · 2022: $14.05 · 2023: $53.35 · 2024: $91.12 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $323.75 | 2020-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $135.94 | 2020-2024 | Jardiance |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $96.47 | 2025 | |
| Abbvie INC. | $83.24 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $75.71 | 2020-2021 | |
| Astellas Pharma US INC | $59.09 | 2020-2021 | |
| Pfizer INC. | $42.49 | 2019-2025 | |
| Allergan, INC. | $34.99 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $25.91 | 2020 | |
| Exact Sciences Corporation | $25.28 | 2023 | Cologuard Collection Kit |
| Sunovion Pharmaceuticals INC. | $24.14 | 2021 | |
| Ironwood Pharmaceuticals, INC | $22.30 | 2021 | |
| Inari Medical, INC. | $20.70 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.32 | 2024 | Caplyta |
| Novartis Pharmaceuticals Corporation | $15.11 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $14.98 | 2019 | |
| Glaxosmithkline, LLC. | $13.87 | 2020 | |
| Sanofi Pasteur INC. | $13.04 | 2019 | |
| Dexcom, INC. | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nahid Islam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.